CFO Ann Kelly reported, “We were pleased to report full year 2025 diluted EPS of $2.92 and adjusted diluted EPS of $2.99. This compares to full year 2024 diluted EPS of $2.87 and adjusted diluted EPS ...

The diluted loss per share for the three months ended June 30, 2024 was determined excluding the effect of 3.82 million dilutive shares as the impact of such shares would have been antidilutive due to ...

Q4 2025 earnings call recap: revenue/EPS beats, margin expansion, Nevro integration, and raised 2026 guidance—read key takeaways.

Information reconciling certain forward-looking GAAP measures to non-GAAP measures related to FY 2025 guidance, including organic net sales growth, adjusted operating margin and adjusted free cash ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and ...

Q4 2025 Management View CEO Lynn Bamford opened the call by highlighting a record year, emphasizing that "we continue to deliver on our pivot to growth strategy, which resulted in strong growth in ...

Q4 2025 Management View CEO Avner Applbaum highlighted that "2025 was a solid year for Valmont. Our team delivered strong performance as they continue to navigate a mixed demand environment, ...

Information reconciling certain forward-looking GAAP measures to non-GAAP measures related to FY 2026 guidance, including organic net sales growth, adjusted operating margin and adjusted free cash ...